Tag Archives: proprotein convertase subtisilin/kexin 9 inhibitor (PSCK9i)

Introduction Control of hypercholesterolaemia has been established as a highly effective first-line management in acute coronary syndrome (ACS) patients.1,2 Data from a meta-analysis of randomised-controlled trials demonstrated that for each 1 mmol/L reduction in low-density lipoprotein (LDL)-cholesterol (LDL-C), statins reduced major cardiovascular (CV) events (myocardial infarction [MI], CV death, any stroke or coronary revascularisation) by an estimated 22%.3 National Institute for Health and Care Excellence (NICE) and international guidelines recommend fasting lipid profiles before, and within three months following, the initiation of hi